The company
Vivmark Residential Common Shares of Beneficial Interest
VMRK · NYSE
We hold no 150-day reading for VMRK yet: it needs about 200 sessions of history. REITs: 17% of its 170 stocks in an uptrend (±0 points in four weeks); Real Estate: 16% (−1 points in four weeks).
Statistics
- Rotation
- not in the set
- Weeks in an uptrend
- —
- Industry in uptrend
- 17% 0 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $9.3M
- Officials’ trades on record
- 0
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.
REITs: Few of its stocks are in an uptrend and the share has held steady. Real Estate: Few of its stocks are in an uptrend and the share has held steady.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Chris CarrDirector | sold | 1,130at $65.28 | 9 Sep 2026filed 11 Sep 2026 |
| Sean Thomas WillsonSenior Vice President & CAO | sold | 300at $66.31 | 21 Aug 2026filed 24 Aug 2026 |
| Sean Thomas WillsonSenior Vice President & CAO | sold | 250at $64.32 | 19 Aug 2026filed 19 Aug 2026 |
| Christopher B. HowardDirector | sold | 8,486at $64.00 | 18 Aug 2026filed 19 Aug 2026 |
| Charles E. Mueller, Jr.Director | sold | 8,000at $63.90 | 18 Aug 2026filed 19 Aug 2026 |
| Susan SwanezyDirector | sold | 15,700at $63.80 | 18 Aug 2026filed 19 Aug 2026 |
| Edward M. SchulmanEVP, Legal Affairs | sold | 16,595at $64.29 | 18 Aug 2026filed 19 Aug 2026 |
| Michael L. ManelisExecutive Vice President & COO | sold | 7,825at $64.31 | 17 Aug 2026filed 19 Aug 2026 |
| Catherine CarrawayEVP & CHRO | sold | 749at $63.56 | 18 Feb 2026filed 19 Feb 2026 |
| Ian KaufmanChief Accounting Officer | sold | 909at $63.56 | 18 Feb 2026filed 19 Feb 2026 |
| Michael L. ManelisExecutive Vice President & COO | sold | 2,429at $63.56 | 18 Feb 2026filed 19 Feb 2026 |
| Catherine CarrawayEVP & CHRO | sold | 656at $65.13 | 10 Feb 2026filed 11 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
No headline names it lately.
Everyone who traded it
Same industry
No other stock in its industry this week.
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.